News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
High-dose cyclophosphamide for graft-versus-host disease prevention.
|Title||High-dose cyclophosphamide for graft-versus-host disease prevention.|
|Publication Type||Journal Article|
|Year of Publication||2010|
|Authors||Luznik L, Jones RJ, Fuchs EJ|
|Journal||Current opinion in hematology|
|Date Published||2010 Nov|
Administration of high-dose cyclophosphamide after transplantation inhibits both graft rejection and graft-versus-host disease (GvHD) in mouse models of allogeneic blood or marrow transplantation (alloBMT). This strategy has recently been adapted to human transplantation.
|Alternate Journal||Curr. Opin. Hematol.|